Treatment of myelodysplastic syndromes
- 31 March 1991
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 5 (1), 42-50
- https://doi.org/10.1016/0268-960x(91)90007-y
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Treatment of patients with myelodysplastic syndromes: A reviewScandinavian Journal of Haematology, 1986
- Myelodysplastic syndromes: a study of 101 cases according to the FAB classificationBritish Journal of Haematology, 1985
- Myelodysplastic syndromes. A clinical and pathologic analysis of 109 casesCancer, 1985
- Control of in vivo differentiation of myeloid leukemic cells. iv. inhibition of leukemia development by myeloid differentiation‐inducing proteinInternational Journal of Cancer, 1984
- Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose CytarabineNew England Journal of Medicine, 1983
- In vivo inhibition of the development of myeloid leukemia by injection of macrophage‐and granulocyte‐inducing proteinInternational Journal of Cancer, 1981
- DIFFERENTIATION OF MYELOID LEUKAEMIC CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1979
- Refractory Anaemia with Excess of Myeloblasts in the Bone Marrow: a Clinical Trial of Androgens in 90 PatientsBritish Journal of Haematology, 1977
- Smoldering acute leukemia. Clinical and cytogenetic studies in six patientsArchives of Internal Medicine, 1971